feed,title,long_url,short_url
Benzinga,Biosimilars Market to Witness CAGR of 18% (2022-2028) Due to Increase in Development of Biologics Drugs Made from Living Organisms | UnivDatos Market Insights,https://benzinga.com/pressreleases/22/12/n29958325/biosimilars-market-to-witness-cagr-of-18-2022-2028-due-to-increase-in-development-of-biologics-dru,
